A Medical Device Daily
Lifeline Biotechnologies (Reno, Nevada) reported that it has finalized an agreement with a First Warning System, a device designed to assist in the early detection of breast cancer.
The underlying technology, upon which the First Warning System holds the possibility of eliminating more than 90% of unnecessary breast biopsies performed each year providing a potential savings of up to $2.8 billion annually. The company says the system could conceivably eliminate the need for suggested MRI's, a savings of another $1.3 billion.
"We have worked with the engineers at the University [in Singapore] for over two years in the preliminary analysis of the patient data which we obtained from our patient testing in Argentina," said Jim Holmes, Lifeline's CEO. "The initial results from this preliminary patient analysis, indicates that the system holds capabilities of identifying breast cancer at a very early stage and at acceptable false positive and false negative levels. Now that the agreement terms are final we will send the additional Argentina patient data for the engineers to analyze and the final development of our First Warning interpretive system."
In other agreement news: MediServe (Tempe, Arizona) reported an agreement with University of California Medical Center (UCSD; San Diego) to deploy MediServe's Respiratory Care solution at UCSD Medical Center-Hillcrest and at UCSD's Thornton Hospital (La Jolla, California).
In conjunction with the deployment, UCSD has chosen to switch from the Clinivision Mobile Patient Charting solution to MediServe's MediLinks application suite, including its ReportLink analytics module, to fully leverage MediServe's expertise in the clinical and business aspects of respiratory care. UCSD Medical Center is part of the renowned University of California system.
MediServe, is a consultant company that works with respiratory care facilities to improve their bottom line.
ProVentive (Boston) reported it has entered into an agreement with Commonwealth Care Alliance (CCA, Boston) to deploy advanced intervention management tool — ProVentive 2.0 — for CCA's senior care and Special Needs Plan products. By integrating ProVentive's software with its own care management capabilities, CCA will more accurately identify seniors and individuals with disabilities at risk of avoidable health events so clinical interventions are timely and optimize both resources and results.
CCA's network of physicians and nurses will monitor patient care, recovery and outcomes of their interventions using ProVentive's web-based care coordination system. CCA will be able to track health risks for its members, as well as social, financial and other factors affecting the ability of seniors to remain independent in the community.
ProVentive is a provider of intervention management solutions for organizations at risk for the cost and quality of health care. CCA is a nonprofit, consumer governed care system.